We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · December 30, 2014

Relapse Outcomes Varies Among Injectable Immunomodulators for MS

Multiple Sclerosis (Houndmills, Basingstoke, England)


Additional Info

Multiple Sclerosis (Houndmills, Basingstoke, England)
Comparative Effectiveness of Glatiramer Acetate and Interferon Beta Formulations in Relapsing-Remitting Multiple Sclerosis
Mult. Scler. 2014 Dec 05;[EPub Ahead of Print], T Kalincik, V Jokubaitis, G Izquierdo, P Duquette, M Girard, P Grammond, A Lugaresi, C Oreja-Guevara, R Bergamaschi, R Hupperts, F Grand'Maison, E Pucci, V Van Pesch, C Boz, G Iuliano, R Fernandez-Bolanos, S Flechter, D Spitaleri, E Cristiano, F Verheul, J Lechner-Scott, MP Amato, JA Cabrera-Gomez, ML Saladino, M Slee, F Moore, O Gray, M Paine, M Barnett, E Havrdova, D Horakova, T Spelman, M Trojano, H Butzkueven

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading